The reliability and accuracy of the CNAP measurement during operations have been confirmed in clinical trials by renowned universities on more than 650 patients.
Draeger developed the CNAP pod to bring this innovative technology to its installed base of Infinity Omega and Omega-S solutions, as well as Delta, Delta XL and Kappa patient monitors.
For more information on Draeger and CNSystems, please visit www.draeger.com and www.cnsystems.at.
Draeger. Technology for Life®
Draeger is a leading international company in the fields of medical and safety technology. Draeger products protect, support and save lives. Founded in 1889, in 2010 Draeger generated revenues of around EUR 2.18 billion. The Draeger Group is currently present in more than 190 countries and has about 11,000 employees worldwide. Please visit www.draeger.com for more information.
CNSystems
Headquartered in Graz, Austria, CNSystems is technology leader in the development of noninvasive medical devices designed for real-time evaluation of all medical conditions characterized by rapid and short-term changes in hemodynamics. With CNAP®, the company succeeded in revolutionizing the method of non-invasive continuous blood pressure monitoring in anesthesiology and perioperative care.
Media Contacts:
Marion Varec: 215-660-2186
Pam Selker Rak: 412-221-4550
Back to HCB News
